This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013;18(1):e2.

doi: 10.1634/theoncologist.2012-0456.

In reply

Timothy Gilligan

PMID: 23355621
PMCID: PMC3556265
DOI: 10.1634/theoncologist.2012-0456

Comment

In reply

Timothy Gilligan. Oncologist. 2013.

. 2013;18(1):e2.

doi: 10.1634/theoncologist.2012-0456.

Author

Timothy Gilligan

PMID: 23355621
PMCID: PMC3556265
DOI: 10.1634/theoncologist.2012-0456

Abstract

Dr. Gilligan responds.

PubMed Disclaimer

Comment on

Is there such a thing as a cancer treatment that isn't worth its cost?
Gilligan T. Gilligan T. Oncologist. 2012;17(1):3-4. doi: 10.1634/theoncologist.2011-0302. Epub 2011 Dec 30. Oncologist. 2012. PMID: 22210088 Free PMC article.
Reply to: Gilligan T. Is there such a thing as cancer treatment that isn't worth its cost? The oncologist 2012;17:3-4.
Graham DM, O'Reilly S. Graham DM, et al. Oncologist. 2013;18(1):e1. doi: 10.1634/theoncologist.2012-0245. Oncologist. 2013. PMID: 23355620 Free PMC article.

Similar articles

Reply to: Gilligan T. Is there such a thing as cancer treatment that isn't worth its cost? The oncologist 2012;17:3-4.
Graham DM, O'Reilly S. Graham DM, et al. Oncologist. 2013;18(1):e1. doi: 10.1634/theoncologist.2012-0245. Oncologist. 2013. PMID: 23355620 Free PMC article.
Is there such a thing as a cancer treatment that isn't worth its cost?
Gilligan T. Gilligan T. Oncologist. 2012;17(1):3-4. doi: 10.1634/theoncologist.2011-0302. Epub 2011 Dec 30. Oncologist. 2012. PMID: 22210088 Free PMC article.
ASPECCT: panitumumab versus cetuximab for colorectal cancer--authors' reply.
Price TJ, Peeters M, Ruff P, Murugappan S, Sidhu R. Price TJ, et al. Lancet Oncol. 2014 Jul;15(8):e303. doi: 10.1016/S1470-2045(14)70291-8. Lancet Oncol. 2014. PMID: 24988928 No abstract available.
Use of bevacizumab in the treatment of metastatic colorectal cancer.
Raouf S, Bridgewater J, Ellis R, Ferry D, Hill M, Wasan H. Raouf S, et al. Br J Hosp Med (Lond). 2012 Jan;73(1):25-30. doi: 10.12968/hmed.2012.73.1.25. Br J Hosp Med (Lond). 2012. PMID: 22241406 Review.
Anti-EGFR monoclonal antibodies for treatment of colorectal cancers: development of cetuximab and panitumumab.
You B, Chen EX. You B, et al. J Clin Pharmacol. 2012 Feb;52(2):128-55. doi: 10.1177/0091270010395940. J Clin Pharmacol. 2012. PMID: 21427284 Review.

See all similar articles

References

1. Staton T. Sanofi Pulls Campath to Clear Way for Higher-Priced Lemtrada. [accessed September 5, 2012]. Available at http://www.fiercepharma.com/story/sanofi-pulls-campath-clear-way-higher-....

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information